These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30015095)

  • 1. HLA-G and anti-HCV in patients on the waiting list for kidney transplantation.
    Sommese L; Paolillo R; Cacciatore F; Grimaldi V; Sabia C; Esposito A; Sorriento A; Iannone C; Rupealta N; Sarno G; Santangelo M; De Rosa P; Nicoletti G; Napoli C
    Adv Med Sci; 2018 Sep; 63(2):317-322. PubMed ID: 30015095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
    Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
    Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
    Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
    Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
    Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection.
    Weng PJ; Fu YM; Ding SX; Xu DP; Lin A; Yan WH
    Hum Immunol; 2011 May; 72(5):406-11. PubMed ID: 21377504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
    Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
    Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?
    Bayraktar A; Akgül SU; Bakkaloğlu H; Temurhan S; Çınar ÇK; Çiftçi HŞ; Kaan Gök AF; Demir E; Oğuz FS; Türkmen A
    Transplant Proc; 2020; 52(1):97-101. PubMed ID: 31901328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble human leukocyte antigen-G (SHLA-G) in Tunisian kidney transplantation.
    Bardi R; Sfar I; Aounallah-Skhiri H; Kallala C; Abderrahim E; Ben Abdallah T; Gorgi Y
    Arch Inst Pasteur Tunis; 2011; 88(1-4):42-6. PubMed ID: 23461142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.
    Okushi Y; Okino K; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
    Clin Exp Nephrol; 2017 Oct; 21(5):932-940. PubMed ID: 28364323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G expression in the peripheral blood of live kidney transplant recipients.
    Xiao L; Zhou WQ; Shi BY; Feng K; He XY; Wei YX; Gao Y; Meng XY; Xiao W
    Chin Med J (Engl); 2013 Jul; 126(14):2652-5. PubMed ID: 23876890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance.
    Hauer V; Risti M; Miranda BLM; da Silva JS; Cidral AL; Pozzi CM; Contieri FLC; Sadissou IA; Donadi EA; Augusto DG; Bicalho MDG
    PLoS One; 2019; 14(2):e0212750. PubMed ID: 30794652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
    Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
    Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.
    Nomura S; Ito T; Katayama Y; Ota S; Hayashi K; Fujita S; Satake A; Ishii K
    Transpl Immunol; 2019 Apr; 53():28-33. PubMed ID: 30543860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum soluble HLA-G, soluble CD30 is correlated to the time after transplantation in renal transplant recipients].
    Jin Z; Xu C; Duan W; Yang J; Tian P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):947-952. PubMed ID: 28712403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.
    Murdaca G; Contini P; Cagnati P; Marenco S; Pieri G; Lantieri F; Picciotto A; Puppo F
    Clin Exp Med; 2017 Feb; 17(1):93-100. PubMed ID: 26567007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Plasma Levels of Soluble HLA-G and HLA-G Genotypes in Kidney Transplant Recipients.
    Piancatelli D; Maccarone D; Colanardi A; Sebastiani P; D'Anselmi F; Iesari S; Binda B; Pisani F
    Transplant Proc; 2020 Jun; 52(5):1559-1561. PubMed ID: 32217007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.
    Orandi BJ; Luo X; Massie AB; Garonzik-Wang JM; Lonze BE; Ahmed R; Van Arendonk KJ; Stegall MD; Jordan SC; Oberholzer J; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Nelson PW; Wellen J; Bozorgzadeh A; Gaber AO; Montgomery RA; Segev DL
    N Engl J Med; 2016 Mar; 374(10):940-50. PubMed ID: 26962729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation Opportunities of Hepatitis C Virus-Seropositive Patients on the Kidney Waiting List.
    Oruc A; Ersoy A
    Transplant Proc; 2018 Dec; 50(10):3181-3184. PubMed ID: 29803528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
    Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Up-regulation of the sHLA-G5 level by human-mouse chimeric anti-IL-2R monoclonal antibody treatment in kidney transplantation].
    Xiao L; Shi BY; Gao Y; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Han MX
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(8):512-5. PubMed ID: 21418849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.